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ABSTRACT Hemodialysis patients are susceptible to life-threatening arrhythmias whose incidence is
markedly higher during the long interdialytic interval due to electrolyte fluctuations. Noninvasive monitoring
of electrolyte fluctuations, particularly those of potassium, would enable restoring electrolyte balance before
the onset of arrhythmias. This study investigates the feasibility of continuous long-term monitoring of
potassium fluctuations using a single-lead electrocardiogram. We evaluate patient-specific T-wave morphol-
ogy changes in the electrocardiogram using two descriptors: 1) a model-based descriptor, θδ , developed to
account for overall morphology changes, and 2) the currently available descriptor, TSA, sensitive to potassium
levels in single-lead electrocardiograms. Electrocardiograms of 15 hemodialysis patients with pre-existent
cardiac diseases were acquired continuously over the long interdialytic interval along with blood samples at
predetermined time instants. Results reveal that θδ and TSA respond concordantly with potassium levels, and
reacts to potassium lowering medication. The overlapping index of the daily distributions of θδ and TSA are
moderately correlatedwith changes in potassium levels (r = −0.56 and r = −0.57, respectively). θδ exhibits
circadian variation, peaking amidst morning and decreasing until evening. θδ appears to be less affected by
motion-induced noise, which is preferable for ambulatory monitoring. Although long-term monitoring of
potassium fluctuations is feasible even in complicated hemodialysis patients, the presence of concomitant
electrolyte (calcium and bicarbonate) imbalances should be accounted for since it can hamper a reliable
estimation. Considering that intradialytic T-wavemorphologiesmay differ from the onesmanifested between
hemodialysis sessions, future studies should also strive to collect blood samples outside of hemodialysis to
improve electrolyte estimation methods.
INDEX TERMS Chronic kidney disease, electrolyte imbalance, hemodialysis, hyperkalemia, hypocalcemia,
metabolic acidosis, sudden cardiac death, T-wave parametrization.
I. INTRODUCTION
Hemodialysis (HD) patients have a considerably higher risk
of sudden death due to cardiac arrhythmias, such as extreme
The associate editor coordinating the review of this manuscript and
approving it for publication was Mohammad Zia Ur Rahman .
bradycardia and ventricular tachycardia [1], which are more
frequent during the long interdialytic interval [2]–[4]. Elec-
trolyte fluctuations, particularly those of potassium, are reck-
oned to be among the primary triggers of these dangerous
arrhythmias [2], [4]. Unfortunately, the asymptomatic nature
of electrolyte fluctuations, along with the fact that blood
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FIGURE 1. Data acquisition protocol. Lead-I ECG signals of hospitalized and ambulatory patients were acquired throughout
the long interdialytic interval using an ambulatory recorder. Blood samples of hospitalized patients were collected twice
during each HD (start and end) and at least once during the long interdialytic interval. Blood samples of ambulatory patients
were collected only through the course of each HD (start, mid, and end).
testing is neither routinely requested, nor can be performed
at home, often engenders life-threatening conditions [4].
Accordingly, long-term noninvasivemonitoring of electrolyte
fluctuations could be of clinical importance [5], [6] as it
would allow a timely correction of electrolyte imbalance by
performing early HD.
Electrolyte fluctuations are often reflected in the elec-
trocardiogram (ECG) since non-homeostatic serum elec-
trolyte levels perturb the resting membrane potential of heart
cells [7], [8]. For instance, an altered T-wave morphology,
caused by disturbances in ventricular repolarization, is a man-
ifestation of anomalous serum potassium [8], [9]. However,
identifying electrolyte fluctuations from an ECG is challeng-
ing [10], [11], especially if no baseline ECG is available for
comparison [12], mainly due to confounding factors, such
as cardiovascular comorbidities, medications or concurrent
electrolyte imbalances, that mask or mimic the anticipated
ECG alterations [9], [12]. The ambiguity of the emblem-
atic ECG features profoundly contributes to the low ECG
specificity, particularly when cardiovascular comorbidities
are present [10]. Thus, exploring ECG-derived descriptors
with higher specificity to serum electrolyte levels is crucial
for noninvasive monitoring of electrolyte fluctuations.
A pioneering 12-lead ECG-based descriptor, TSA, was
proposed for the quantification of serum potassium dur-
ing HD [13]. Mayo Clinic researchers further enhanced
the descriptor for use in a single-lead ECG, first
precordial [14], [15], and later in lead-I acquired from a
handheld device [16]. The descriptor was further compared
to another descriptor, which evaluates the complete T-wave
morphology [17], and studied under electrophysiological
modeling [18]. Albeit with encouraging results, these stud-
ies investigated the descriptors’ performance exclusively
during HD procedures; thus, the feasibility of long-term
ambulatory monitoring of potassium fluctuations remains
unexplored. In interdialytic settings, serum electrolyte lev-
els may fluctuate more gradually than during HD, where
electrolyte levels usually are corrected in approximately 4 h.
Rapid fluctuations of serum electrolyte levels induce cardiac
instability [19], resulting in noticeable T-wave morphol-
ogy changes [20], [21], as typically seen throughout HD.
However, when electrolyte levels vary slowly, such changes
are less apparent and may not be distinctively quantifiable,
especially in HD patients who may develop compensatory
mechanisms or manifest antagonist electrolyte levels that
stabilize the cardiac membrane potential [19].
This study explores the feasibility of capturing potas-
sium fluctuations over the long interdialytic interval using a
single-lead ECG. The study aims to understand the current
challenges of long-term noninvasive monitoring of such fluc-
tuations during activities of daily living where: (i) potassium
may fluctuate slowly, (ii) concomitant electrolyte imbalance
may arise, and (iii) underlying cardiac diseases prevail. Con-
sidering that potassium fluctuations may affect the overall
T-wave morphology and TSA relies on local T-wave features,
we developed a model-based descriptor to account for global
T-wave morphology. In contrast to other studies, we tracked
T-wave morphology changes continuously between HD ses-
sions in patients with several cardiac diseases as a realistic
representation of the HD population. We investigate in detail
patient-specific responses of T-wave morphology changes to
gradual electrolyte fluctuations. In adition, we tested the per-
formance of the descriptors in different signal quality periods.
This paper is organized as follows. Firstly, we describe a
model-based descriptor to monitor serum potassium fluctua-
tions in a single-lead ECG. Secondly, we present results on a
database recorded during the long interdialytic interval. The




Seventeen HD patients (9 females, age 57.4 ± 14.6 years),
hospitalized or ambulatory, from the Hospital of Lithuanian
University of Health Sciences Kaunas Clinics, were eligible
for this study. The study was approved and carried out follow-
ing the recommendations of the Kaunas Regional Biomedical
Research Ethics Committee (#BE-2-43), including written
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FIGURE 2. Preprocessing of a single-lead ECG.
informed consent from all patients per the Declaration of
Helsinki.
Hospitalized patients were not bedridden and were free to
move in hospital facilities. Lead-I ECG was acquired during
the long interdialytic interval (∼71 h for each patient, a total
of∼1078 h) using Bittium Faros (Bittium Corporation, Oulu,
Finland) ambulatory recorder at a sampling rate of 500Hz.
Data acquisition started before the last HD of the week, either
Friday or Saturday, and ended after the following HD on
Monday or Tuesday (Fig. 1). From this point onwards, Friday
HD refers to the last HD of the week, whereas Monday HD
denotes the following HD.
Blood samples were drawn twice (start and end) during
each HD procedure from hospitalized patients, and thrice
(start, mid, and end) from ambulatory patients to assess serum
potassium ([K+]), magnesium ([Mg2+]), calcium ([Ca]) and
bicarbonate ([HCO−3 ]) levels. At least one additional blood
sample between HD sessions was collected from hospitalized
patients at a predetermined time instant, decided by the physi-
cian on call. All patients were also asked to register the time
of meal and medication intake.
Out of 17 patients, two were excluded from the analy-
sis. One patient presented ventricular tachycardia episodes
during the recording and was taken to the intensive care
unit, while the other terminated recording just a few hours
after Friday HD due to discomfort. Two hospitalized patients
required urgent HD one day earlier. Patients were divided
into two groups: Group I comprises patients with regular
sinus rhythm and high signal quality over the whole recording
period, whereas Group II includes patients whose record-
ings were noisy, with arrhythmias or affected by ingestion
of potassium-lowering medication (Sorbisterit). Patients in
both groups manifested concomitant electrolyte imbalances
(calcium, bicarbonate, and magnesium). Table 1 provides
patient and recording characteristics.
B. ECG PREPROCESSING
The recorded ECGs underwent preprocessing comprised of
filtering, signal quality assessment, heart rate-based correc-
tion of T-wave duration, beat averaging, and T-wave rectifi-
cation (Fig. 2).
1) FILTERING
For a reliable assessment of electrolyte fluctuations, it is cru-
cial to avoid distortions in the ST-segment and T-wave. Thus,
the ECGs were filtered using a combination of high-order
finite impulse response filters. Baseline wandering was
removed by using an 836th order high-pass filter with a cut-off
frequency of fc = 0.6Hz, whereas high-frequency noise was
suppressed using a 16th order low-pass filter with fc = 40Hz.
2) SIGNAL QUALITY ASSESSMENT
A 90-s sliding windowwith 10-s overlap was used to segment
the ECGs, discarding heartbeats that did not fulfill the sig-
nal quality index (SQI) criteria proposed in [22]. Segments
with more than 50% poor-quality beats were considered
non-analyzable.
Each ECG was divided into three days: Day 0, covering
the remaining hours of the same day after Friday HD (until
22:00), Day 1, and Day 2 as the ensuing and last days of the
long interdialytic interval, respectively. Since lying positions
can considerably alter the ECG morphology [23], Day 1 and
Day 2 range from 07:00 till 22:00 as patients were usually
awake within this period and the likelihood of encountering
a lying position was reasonably low. ECG segments within
episodes of arrhythmogenic events were excluded from the
analysis.
3) HEART RATE CORRECTION
T-wave morphology is sensitive to heart rate changes, which
must be rectified before evaluating the influence of serum
electrolyte levels. Thus, the ST-T complex duration was
resampled to fit the current RR interval, according to
Fridercia’s formula [24].
4) BEAT AVERAGING
The resampled heartbeats were aligned and averaged within
each 90-s segment, resulting in a single representative heart-
beat. QRS complex and T-wave onset were delineated using
ecg-kit toolbox [25], whereas T-wave offset as described
in [26]. Feature estimation was applied to the delineated
T-waves of each averaged heartbeat.
5) T-WAVE RECTIFICATION
Each delineated T-wave, T (n), was preprocessed through a
series of steps to transform different waveforms as closely as
possible to a positive T-wave. Accordingly, negative T-waves
were inverted, T (n) = −T (n). In waveforms with ST depres-
sion, the T-wave onset was amended to the local minimum
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TABLE 1. Patient and recording characteristics.
amplitude point. Once the onset and offset were delineated,
the T-wave baseline was corrected to begin and end at zero
amplitude. A baseline was estimated by linear interpolation
between T-wave onset and offset, and subtracted from T (n).
Then, T (n) was standardized to counteract amplitude dis-






where T z(n) denotes the standardized T-wave, x̄ and s
are the mean and standard deviation of T (n), respectively.
From this point onwards, T z(n) denotes the standardized
T-wave, whereas T (n) the baseline-removed T-wave.
C. T-WAVE PARAMETRIZATION
Model-based parametrization was employed to quantify
electrolyte-induced changes in T-wave morphology. The
T-wave, composed of two asymmetrical slopes—upward
and downward—was modeled using a composite model of
two functions to characterize each slope separately. The
model, inspired by the one proposed in [27] and [28], and
briefly described in [29], consisted of one Gaussian and one
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FIGURE 3. T-wave composite model.
lognormal functions (Fig. 3). The Gaussian function con-
strued the upward slope and is defined by:







where n represents sample number, µu and σu are the loca-
tion and scale parameters. The lognormal function, which
depicted the downward slope, is defined by:










where γd , µd and σd stands for the location, scale, and
shape parameters, respectively. The time-shifting parameter
γd ensures that Td (n) always fits the downward slope without
modifying the shape and scale of the model. In this man-
ner, we ensured an unambiguous reaction of µd and σd to
morphological, but not temporal changes. T (n) can then be
characterized by combining (2) and (3) as:
Tc(n) = wuTu(n)+ wdTd (n)+ h. (4)
The subscript c denotes the fitted composite model, whereas
u and d imply that the parameters represent the upward and
downward slopes. Both functions are weighted by parameters
wu and wd , and balanced with an offset h. The parameters are
merged into the vector φ = [σu, σd , µu, µd , γd ,wu,wd , h],
which was estimated using the trust-region reflective
least-squares algorithm with a set of empirically determined
lower and upper boundaries to control the fitting process.
Supplementary table 2 briefly presents such boundaries,
along with values used to initialize φ. Before parameter-
ization, T (n) was resampled to 1000 samples, normalized
to unit amplitude, and mirrored in time, T̂ (n) = T (−n).
This step ensures that T̂ (n) becomes right-skewed as a log-
normal, increasing the coefficient of determination R2 and
improving goodness of fit. Fitting is considered acceptable
when R2 exceeds the empirically chosen fixed threshold
of 0.8. Otherwise, waves were considered of poor quality
and thereby discarded from the analysis. Flat T-waves were
excluded from the analysis since parametrization of such
waves is unavailing. Figure 4 depicts T-wave rectification and
parametrization for several ECG morphologies encountered
in the data. Appendix B presents pseudocodes for the T-wave
rectification and parametrization algorithms.1
1Note to readers: The code is available on GitHub. Repository name:
T-waveModelPotassiumFluctuations
D. T-WAVE FEATURE ESTIMATION
When serum [K+] starts to rise above normal levels,
the T-wave tends to become more peaked and decreases in
duration [7], [9]. To quantify variations in T-wave peaked-
ness, we estimated the angle θ between the upward and
downward slopes (Fig. 5a-b). Assuming that each slope is
defined as a line with gradient S, θ was calculated by:
θ = β − α ≡ arctan(Sd )− arctan(Su), (5)
where β and α are the angles between the temporal axis and
the downward and upward slope, whereas Su and Sd are
the gradients of the correspondent slopes. Su and Sd were
estimated from T z(n) in a similar way as in [30]: two lines
were computed in an 8ms window centered at the maximum
gradient between T-onset and T-peak, and at the minimum
gradient between T-peak and T-offset (Fig. 5c). Su and Sd
are the yielded gradients of the fitted lines in a.u./s.
As the duration of repolarization shortens, the T-wave
becomes less elongated. Given that each function from the
composite model depicts a slope, changes in T-wave elon-
gation were characterized by a temporal displacement, δ,
between the points of global maximum of Td (n) and Tu(n)
functions (Fig. 5d-e). Considering that the point of global
maximum of a probability distribution is its mode, δ was
found by:
δ̂ = md − mu, (6)
where md and mu are the modes of lognormal and Gaussian
functions. The mode of a Gaussian function is given by µu,
whereas, for the three-parameter lognormal function, it was
calculated as follows:
md = γd + e(µd−σ
2
d ). (7)
Given that δ̂ was estimated from the resampled T̂ (n), δ was





where N is the number of samples in T (n). Conceptually,
as serum [K+] starts to rise slowly during the long inter-
dialytic interval, the T-wave becomes narrower and more
peaked, translating into lower values of δ (s) and θ (◦). Since
θ and δ vary concordantly with each other, both decreasing
when [K+] increases, we propose a new descriptor, θδ , that
amplifies their response to serum [K+] fluctuations:
θδ = − log10(θ · δ). (9)
The logarithm expands the dynamic range and ensures that θδ
is positively correlated with [K+] levels.
E. PERFORMANCE EVALUATION
The performance of the proposed descriptor, θδ , was com-
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FIGURE 4. T-wave rectification and parametrization for various ECG morphologies encountered in the data. After
delineating the T-waves for every valid averaged heartbeat, the T-wave was rectified, mirrored, resampled,
normalized, and subjected to parametrization.
Sd (in a.u./s) is the downward slope and TA is the peak-
to-peak amplitude between the T-wave peak and offset.
Sd and TA were computed from the non-mirrored T (n), nor-
malized by the signal energy of its correspondent QRS-wave,
as described in [15]. It should be noted that TSA is not appli-
cable for negative T-waves [15]. Despite being often used by
clinicians to identify potassium abnormalities, the emblem-
atic T-wave amplitude was not included for comparison, since
it shows inferior performance to that of TSA [14].
To examine the daily variation of θδ and TSA relative to
the [K+] reference values of each individual, kernel density
estimations were used to obtain distributions of θδ − θδt0 and
TSA − TSAt0 . The reference values were calculated at t0 by
finding the mean during the first 30min following Friday HD
termination. Within this 30min period, [K+] remains nearly
unchanged as none of the patients had a meal, thus avoiding
insulin spikes that drive serum [K+] intracellularly [31].
The overlapping index η [32] was used to quantify sim-
ilarities between the daily distributions of θδ and TSA. The
index η can take values between zero and one, where η = 1
indicates that the two distributions are identical. Intuitively,
it is expected that higher [K+] fluctuations will translate into
smaller η values. The relationship between η and1[K+] was
assessed using Pearson’s correlation coefficient (r), where
1[K+] is expected to be negatively correlated with η. η was
calculated between the days with assessed [K+], which, for
the majority of patients, is solely between Day 0 and Day 2.
Since blood was collected at the start of Monday HD, Day 2
distribution includes 2 h preceding Monday HD as well. The
subscript of η specifies the days between which η is evalu-
ated, whereas1[K+] denotes the difference of [K+] between
two days.
To investigate noise robustness of θδ and TSA in more
detail, we compared the coefficient of variation, cv, of each
descriptor within periods during which [K+] levels remain
nearly unchanged, but the signal quality was expected to vary.





where s and x̄ are the standard deviation and mean of either
θδ or TSA within a given period, respectively. Lower cv values
within periods of low signal quality indicate higher descriptor
stability and, therefore, more robustness to noise.
Since ambulatory signals are recorded in an unsupervised
fashion, cv was measured in two different periods: t1 =
[21:00–22:00] of Day 1 and t2 = [00:00–01:00] of Day 2.
During t1, the patients were still awake, and the ECGs
were expected to have lower quality due to movement (e.g.,
walking around the house). Conversely, during t2, patients
were asleep and physical activity was minimal, thereby
increasing quality. We confirmed this through accelerometer
signals recorded synchronously with the ECGs. The peri-
ods t1 and t2 were chosen for two reasons: (i) intra- and
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FIGURE 5. T-wave feature estimation: (a) T-waves before and after HD
without normalization; (b) variation of θ in normalized T-waves before
and after HD; (c) finding of Su, Sd and θ . The change in δ: (d) before HD
([K+] = 5.5 mmol/L) and (e) after HD ([K+] = 3.2 mmol/L).
intercellular [K+] changes are likely more stable during
Day 1 and Day 2, unlike during the same day after
HD [33]; (ii) the circadian variability of serum [K+] in
patients with impaired renal function indicates that [K+]
levels between 21:00 till 01:00 increase, on average, only
0.06 mmol/L [34], which is minimal. Although the circadian
variability of serum [K+] in HD patients has not been stud-
ied, we observed that θδ responded similarly to the findings
in [34] (see Fig. 9), thus implying that the circadian rhythm is
maintained.
III. RESULTS
Figure 6 depicts the variation of θδ and TSA in patients of
Group I. As expected, θδ and TSA rise with the increase of
[K+]. Note the low trendline steepness for patient #6 which
corresponds well with little change in [K+]. Interestingly, TSA
varies in the opposite direction in patient #4 who displayed
positive and negative T-waves, and occasional ST depression.
θδ appears to better deal with alternating T-wave morpholo-
gies than TSA.
Figure 7 shows the feature variation in patients of Group
II of problematic recordings. Unsurprisingly, θδ and TSA
show trends discordant with [K+] levels in patients with:
atrial fibrillation (#8), premature atrial contractions (#9), and
tachycardia (#9, #10, #14). Nevertheless, in periods of sinus
rhythm, duringwhich the T-wavemorphology stabilizes, both
descriptors varies agreeably with [K+] levels.
Most of the time, flat or negative T-waves prevailed in
patients #5 and #12, who manifested severe isolated hypocal-
cemia. TSA could only be computed during the short time
intervals in which the T-wave was positive. Curiously, both
patients displayed discrepantly high θδ values despite the
absence of hyperkalemia, likely due to T-wave narrowing
during ST-T complex resampling used for correction of
heart-rate induced T-wave changes.
In patients with hyperkalemia concomitant with metabolic
acidosis (#10, #11, #13), TSA showed amore prominent trend-
line steepness, possibly due to the overlaying effects of both
electrolytes on the T-wave downward slope.
The daily distributions of θδ − θδt0 and TSA − TSAt0 are
given in Fig. 8. As anticipated, η responds inversely to [K+]
variations, i.e., lower η values (patients #1–4, #8, and #12)
indicate a higher increase in [K+] and, thus a smaller over-
lap of distributions, and vice-versa (patients #6, #10). The
Pearson’s correlation coefficient shows that both descriptors
are moderately correlated with changes in [K+], being r =
−0.56 (p<0.01) for θδ and r = −0.57 (p<0.01) for TSA.
When calculated for each group separately, the correlation is
much stronger in Group I with r = −0.81 (p>0.01) for θδ
and r = −0.79 (p>0.01) for TSA, with Group II showing
a weaker correlation of r = −0.45 (p>0.01) for θδ and
r = −0.44 (p>0.1) for TSA. It appears that θδ is more stable
than TSA except for #9, #14, and #15, for whom η0−2 show
unexpected values compared to 1[K+]0−2. In patients who
displayed both metabolic acidosis and hyperkalemia (#10,
#11, and #13), TSA shows lower η0−2 values for 1[K+]0−2.
Broader distributions are observed in patients #4, #5, #9, #12,
and #15 who exhibited T-wave morphologies across the long
interdialytic interval different from those used to estimate θδt0
and TSAt0 . A decrease of θδ and TSA during Day 0 is visible in
the majority of patients, possibly due to insulin spikes during
meals which can drive [K+] intracellularly.
Figure 9 shows the mean of θδ across all patients in
non-overlapping 10min intervals from 07:00 till 22:00. Dur-
ing Day 1 and Day 2, θδ shows higher values in the morn-
ing, peaks around lunch time ([12:00-14:00]), and decreases
across the afternoon until the evening. Also θδ increases
during the night as θδ is higher at 07:00 of Day 2 compared
to 22:00 of Day 1.
Figure 10 shows the dispersion of cv for θδ and TSA
within the periods of low (t1) and high (t2) signal quality.
As envisaged, both descriptors show higher cv values during
t1. However, θδ displays lower dispersion of cv during t1,
suggesting greater stability in noisy conditions than TSA.
While the median difference of TSA is minimal between t1
and t2, TSA exhibits a large dispersion during t2. In contrast,
θδ seems to bemore constant in less noisy conditions. Patients
#8 and #12 were excluded from this analysis as #12 displayed
T-wave inversion (for which TSA cannot be estimated) and
#8 manifested atrial fibrillation during t1 and t2.
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FIGURE 6. Variation of θδ (top row) and TSA (bottom row) together with the estimated linear trend (solid blue line) and [K+] values (red dots, dashed
line) for individual patients of Group I. The linear trends are estimated using the best-fit linear polynomial between the consecutive time instances
of [K+] assessments. Grey patches depict periods of negative T-waves, during which θδ is computed without any correspondent TSA values. Yellow
patches depict periods of intravenous (IV) iron infusion which may affect T-wave morphology. Patient #5 was taken to HD one day earlier and, thus
no blood was taken between HD sessions. The blood samples from Friday HD of patient #7 were misplaced hence the absent trendline. Dots of
different colors highlight patients who displayed metabolic acidosis (yellow) or severe hypocalcemia and metabolic acidosis (blue and yellow).
FIGURE 7. Variation of θδ (top row) and TSA (bottom row) together with the estimated linear trend (solid blue line) and [K+] values (red dots,
dashed line) for individual patients of Group II. The linear trends are estimated using the best-fit linear polynomial between the consecutive time
instances of [K+] assessments. Grey patches depict periods of negative T-waves, during which θδ is computed without any correspondent TSA
values. Red patches depict periods of arrhythmias: atrial fibrillation (AF) and premature atrial contractions (PACs). Patient #14 was taken to HD one
day earlier. The blood sample at the end of Friday HD of patient #10 was misplaced. Dashed vertical line denotes the time of Sorbisterit (Sorb)
intake, whereas blue patches depict the duration of Sorbisterit effect. Dots of different colors highlight patients who displayed metabolic acidosis
(yellow), severe hypocalcemia (blue) or both.
IV. DISCUSSION
A. DESCRIPTORS RESPONSIVENESS TO POTASSIUM
FLUCTUATIONS
We quantified gradual electrolyte-induced T-wave changes
using model-based parametrization. The yielded parameters
of such models can act as surrogates of important physi-
ological traits that cannot be straightforwardly determined
(e.g., T-wave duration) [35]. Additionally, model-based
parametrization enables a global evaluation of the T-wave
morphology and may increase robustness to noise [36],
which is frequent in ambulatory ECG recordings. We tracked
T-wave morphology changes using two descriptors: θδ ,
and TSA. The progression of θδ and TSA during the long
interdialytic interval is promising, both showing an appealing
potential to become estimators of serum [K+]. Even in a
group of patients with various underlying cardiac diseases,
θδ and TSA are responsive to [K+] fluctuations, indicating
that long-term monitoring of such fluctuations is feasible.
Furthermore, θδ exhibited higher stability during noisy peri-
ods compared to TSA, which is advantageous for ambulatory
monitoring.
Interestingly, the descriptors showed increased variability
during Day 0 compared to Day 1 or Day 2. The presence of
such variability is plausible since the effects of HD-induced
hemodynamic stress could, presumably, still be felt for hours
after HD, thus affecting T-wave morphology. The existence
of such a transient period, during which the T-wave mor-
phology can differ from the one manifested during the long
interdialytic interval, may have substantial implications on
[K+] estimation. One approach for ECG-based estimation of
[K+] levels can be the use of a reference T-wave of each
individual at a known [K+] level. Indeed, previous stud-
ies have shown a decrease in the error of [K+] estimation
after patient-specific calibration [13], [15]. However, these
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FIGURE 8. Distribution of θδ − θδt0 (left) and TSA − TSAt0 (right) of Group I (top) and Group II (bottom) during
the long interdialytic interval. η0−2 is the overlapping index between the distributions of Day 0 and Day 2,
whereas 1[K+]0−2 is the increment of [K+] between the end of Friday HD and the start of Monday HD. The
number of intervals during Day 2 is small in patients #5 and #14 who were taken to HD one day earlier. The
blood samples from Friday HD of patients #7 and #10 were misplaced (ND stands for no data). In patient #10,
blood was collected on Day 1.
studies focused on assessing [K+] levels during HD exclu-
sively, where the same T-wave morphology—similar to that
used to estimate reference values—persists throughout HD.
Using T-waves acquired during or immediately after HD as
a reference may result in [K+] estimation errors when the
morphology alters. Thus, days between HD sessions should
preferably be used for reference T-wave assessment.
Another finding is the apparent circadian periodicity of θδ ,
suggesting that [K+] naturally fluctuates during the day in
HD patients similarly to healthy subjects [34]. Although there
is a lack of studies examining the circadian rhythm of serum
[K+] levels in HD patients, the existence of such circadian
variability in these patients is still plausible. With little to
no renal function left, as an attempt to maintain [K+] home-
ostasis, HD patients heavily rely on aldosterone-regulated
colonic [K+] secretion [37], [38]. While the circadian rhythm
of aldosterone is well understood in healthy subjects [39], it is
unclear whether HD patients maintain such circadian rhythm.
Our study showed that θδ and TSA started to decrease
2 h after the intake of potassium-lowering medication
(Sorbisterit), which is compatible with its onset of action.
The decrease of θδ and TSA lasted about 10 h and is within
the range of expected duration of the Sorbisterit effect. This
observation needs to be taken into account to understand bet-
ter how Sorbisterit, or other standard medications prescribed
to HD patients, alters the T-wave morphology.
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FIGURE 9. Mean of θδ (dots) across all patients in non-overlapping
10 intervals from 07:00 till 22:00 during Day 1 and Day 2. Solid line is a
fitted 7th order polynomial to show a smoother variation of θδ . The upper
and lower boundaries represent the standard deviation of the fitted
polynomial.
FIGURE 10. Boxplot of coefficient of variation cv computed for each
patient during two different signal quality periods: t1 = [21:00–22:00] of
Day 1 (lower signal quality) and t2 = [00:00–01:00] of Day 2 (higher
signal quality).
B. EVALUATION OF SERUM POTASSIUM WITH
CONCURRENT CALCIUM IMBALANCE
Compared to TSA, the range of θδ values is narrower and
more consistent across the dataset, except for patients with
isolated severe hypocalcemia (#5 and #12), both free from
any pre-existent cardiac issues. Intriguingly, these patients
exhibited high θδ values without hyperkalemia. We found
atypically low values of δ in these patients, which indicate
T-wave narrowing as, conceptually, δ mostly depends on
T-wave duration. Considering that the T-wave duration is not
affected by calcium imbalance with normal [K+] levels [9],
δ should not have reacted in this manner. We suspect that
resampling of the ST-T complex, distinctively prolonged in
hypocalcemia [9], may have affected the T-wave duration.
While flattened or negative T-waves can be prominent in
isolated calcium abnormalities [9], [40], particularly in severe
levels, changes in ST-segment duration are the most dis-
cernible marker of [Ca] levels [9]. Although this study did not
analyze in detail the effects of [Ca] on the ECG, we observed
a prolonged ST-segment in three patients who displayed
severe hypocalcemia. However, ambulatory estimation of the
ST-segment duration is challenging, particularly in patho-
logical conditions of ST-segment deviations, as frequently
encountered in HD patients. For instance, in patient #10 with
ST-elevation characteristic of left ventricular hypertrophy
(LVH), the ST-elongation was not as blatant in lead-I as in
patients #5 and #12, both without ST-deviations. Perhaps in
cases of ST-segment deviations, relying on other ECG leads
can mitigate this problem.
Recognizing abnormal calcium levels may improve the
detection of dangerous serum [K+] levels for twofold rea-
sons. Firstly, isolated calcium imbalance can alter the T-wave
morphology [9], thus interfering with the assessment of
potassium-induced T-wave changes. Secondly, [Ca] and [K+]
have a complex relationship which affects the intra- and atri-
oventricular conduction within the heart [9], meaning that the
harmfulness of [K+] levels, either in hypo- or hyperkalemia,
is tightly dependent on [Ca] levels [7]. For instance, hyper-
calcemia antagonizes, whereas hypocalcemia exacerbates the
consequences of hyperkalemia [21]. Determining the pres-
ence of calcium imbalance can aid in ascertaining whether
the measured [K+] level is alarming or not.
C. EVALUATION OF SERUM POTASSIUM WITH
CONCURRENT ACID-BASE IMBALANCE
Along with concurrent calcium imbalance, we also
encountered difficulties in detecting [K+] fluctuations in the
presence of an acid-base disturbance (i.e., abnormal [HCO−3 ]
levels). When acidosis emerges, the electrophysiological
effects of hyperkalemia are, expectedly, aggravated [21].
Consequently, one would anticipate θδ and TSA to respond
with higher values in such conditions, which was not entirely
the case in patients with hyperkalemia and acidosis. Curi-
ously, though rare, severe hyperkalemia with minimal T-wave
changes has been reported in patients who manifested aci-
dosis concurrently [41]. Although noisy recordings or LVH
could reasonably justify such an unexpected variation of θδ
and TSA, the impact of acidosis in [K+] estimation should
not be neglected. Acidosis can instigate T-wave morphology
changes resembling those of hyperkalemia [42]. Using solely
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T-wave-derived features to evaluate [K+] levels when acido-
sis arises, may, therefore, either under- or overestimate [K+]
levels.
A compelling case to mention is patient #15, whose val-
ues of θδ and TSA decreased during the long interdialytic
interval. Besides being the patient with the most complicated
medical history, including chronic heart failure, LVH, and
ischemic heart disease, he was the only patient who expe-
rienced metabolic alkalosis. Even though alkalosis does not
usually cause hypokalemia in HD patients [43], it is peculiar
to see that θδ and TSA decreased. Such behavior of θδ and TSA
is something we would expect in case of [K+] depletion as in
hypokalemia. Since alkalosis-related ECG changes resemble
those of hypokalemia [44], one must pose the question of
whether this unusual descriptor variation results, inherently,
from the heart failure condition, or as a consequence of
alkalosis.
While blood pH imbalance is seldom life-threatening in
itself if not in severe levels [45], identifying acid-base dis-
turbances may not only improve [K+] monitoring but also aid
in assessing the arrhythmogenic potential of [K+]. In addition
to being vastly prevalent in HD patients, acid-base disequilib-
rium can encourage the onset of arrhythmias by (i) impairing
vascular and myocardial function [46], and (ii) influencing
the levels of various electrolytes, including [K+], [Na], and
[Ca] [42], [45]. For instance, metabolic acidosis induces
[K+] shifts from the intracellular to the extracellular space,
potentially leading to hyperkalemia [45]. Thus, identifying
[HCO−3 ] imbalance could enable bettermanagement of serum
[K+]. Nevertheless, with [K+] and [HCO−3 ] compounding
their effects on the T-wave morphology, the feasibility of
utilizing a single-lead ECG to monitor [K+] fluctuations in
the presence of abnormal [HCO−3 ] levels is, at the very least,
contentious. Future studies should address the confound-
ing potential of [HCO−3 ] by exploring other descriptors of
[HCO−3 ] levels.
D. CHALLENGES AND LIMITATIONS
Even with encouraging results, deriving θδ and TSA in ambu-
latory conditions still poses some obstacles to be tackled,
one of them being the inherent complexity of determin-
ing T-wave boundaries in noisy conditions. When tachycar-
dia or an episode of premature atrial contractions (PACs)
occur, the P-wave can partially hide within the preceding
T-wave, resulting in either a disturbed T-wave morphol-
ogy or a misguided delineation of the T-wave. We expe-
rienced difficulties in accurately locating T-waves during
tachycardia or PAC episodes. Even though employing a
SQI detector should have disregarded ECG segments with
premature heartbeats, the SQI used in this work failed
to identify PAC episodes, eliminating exclusively ventric-
ular ectopic beats and noisy segments. Premature heart-
beats, atrial or ventricular, must be detected not only to
avoid erroneously locating the T-wave but also because
alterations in serum [K+] and [Mg2+] can trigger ectopy
and, consequently, arrhythmias [8]. The frequency of ectopy
occurrence might, therefore, be an indicator of electrolyte
fluctuations.
Alternating T-wave morphologies is another issue deserv-
ing further exploration. Independently of whether differ-
ent physiological conditions instigate morphology variations,
the disparity in observed T-wave morphologies, even in the
same patient, further demonstrates the importance of dealing
with various T-wave morphologies. With previous studies
having used, exclusively, intradialytic T-waves to seed mod-
els for quantification of serum [K+], the performance of
such models is, arguably, fettered when encountering differ-
ent interdialytic morphologies. While estimating [K+] lev-
els from T-waves identical to the patient-specific reference
is ideal, it may not always be attainable to do so during
activities of daily living. Availability of multiple ECG leads
and lead-reduction techniques could ameliorate the problem
of alternating T-wave morphologies [47]; however, 12-lead
ECG recorders are often uncomfortable for wearing and
hence unsuitable for long-term monitoring. Handling various
ECG morphologies is, therefore, indispensable for nonin-
vasive monitoring of electrolyte fluctuations. Indeed, in a
highly susceptible group of HD patients, the discrepancy in
T-wave morphologies can stem from many sources, either
psychological stress [48], change in body position [23], phys-
ical activity [49], other electrolyte imbalances [9], or due to
pre-existent cardiac comorbidities. Understanding the causes
of morphology changes in HD patients is pivotal to avoidmis-
classification of other pathologies and electrolyte imbalance.
The small number of patients included in this study, albeit
being a realistic representation of the HD population, cer-
tainly restricts the generalization of our findings, especially
to other populations susceptible to [K+] imbalance. Further-
more, the lack of patients with severe hypo- or hyperkalemia
prevents us from evaluating the descriptor response in such
extreme cases with distinct ECG morphology.
The exploration of additional electrolyte biomarkers is
needed. Having biomarkers of serum [K+], [Ca], and
[HCO−3 ] can facilitate routine electrolyte monitoring, aid in
ascertaining the harmfulness of [K+] levels, and possibly
avert life-threatening conditions. Thus, our future studies will
focus on developing descriptors of [Ca] and [HCO−3 ] levels
and optimize [K+] estimation under concomitant electrolyte
imbalance. Future studies should also strive to collect blood
samples on days between HD sessions and extend to other
patient populations susceptible to [K+] imbalance (e.g., heart
failure).
To the best of our knowledge, this is the first study to
attempt to monitor gradual [K+] fluctuations throughout the
long interdialytic interval, thereby narrowing any possibility
to compare our findings. Nevertheless, we reveal the central
issues to be solved concerning the noninvasive monitoring of
electrolyte fluctuations in HD patients.
V. CONCLUSION
This study demonstrates that long-term noninvasive moni-
toring of [K+] fluctuations is feasible even in complicated
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HD patients with underlying cardiac diseases. Given the
preponderance of alternating T-wave morphologies that can
differ from the one exhibited during HD within the same
patient, reference T-waves should preferably be assessed in
days between HD sessions.
Gradual T-wave morphology changes induced by serum
[K+] can be quantified by model-based parametrization (θµ)
and slope-to-amplitude ratio (TSA). θµ appears to be less
affected by noise than TSA, and, therefore better suited
Algorithm 1 T-Wave Rectification
Input: Delineated T-wave T (n)
Output: Rectified T-wave T (n), standardized T-wave T z(n),
T-wave waverform type
1: procedure TwaveRectification(T (n))
2: T (n)← []
3: T z(n)← []
4: type← Check type of T (n). See Figure 4.
5: if type! = flat then
6: if type == negative then
7: T (n)←−T (n) F Invert T (n)
8: else if type == ST depression then
9: iOnset ← Find local minima index of T (n).
10: T (n)← T (iOnset:n) F Amend T-wave onset
11: end if
12: T (n)←CorrectBaseline(T (n))
13: T z(n)←TwaveStandardization(T (n))
14: end if
15: return T (n), T z(n), type
16: end procedure
17: procedure CorrectBaseline(T (n))
18: baseline← Linear interpolation between T (n) onset
and offset.
19: T (n)← T (n)− baseline
20: return T (n)
21: end procedure
22: procedure TwaveStandardization(T (n))
23: x̄ ← mean(T (n))
24: s← std(T (n))
25: T z(n)← T (n)−x̄s ,∀n. See (1).
26: return T z(n)
27: end procedure
for long-term monitoring during daily activities. However,
the presence of concomitant electrolyte imbalance, primarily
of [Ca] and [HCO−3 ], can hamper a reliable estimation of
[K+] levels and should be accounted for.
APPENDIX A
INITIALIZATION OF THE FITTING ALGORITHM
The lower and upper boundaries, and initial values of the
elements of vector φ are presented in Table 2. These values
Algorithm 2 T-Wave Parametrization
Input: Baseline-removed T-wave T (n)
Output: Parameters σd , µu, µd , γd , and R2
1: procedure TwaveParametrization(T (n))
2: T (n)← resample T (n) to 1000 samples.
3: T (n)← normalize T (n) to unit amplitude.
4: T̂ (n)← T (−n) FMirroring
5: N ←length(T (n))
6: T ic(n;φi)←GetIntitialTemplate(T̂ (n), N )
7: Tc(n;φ),R2←LScurveFit(T ic(n;φi))
8: σd , µu, µd , γd ← extract from φ
9: return σd , µu, µd , γd , R2
10: end procedure
11: procedure GetInitialTemplate(T̂ (n), N )
12: b← N1000
13: np← find T̂ (n) peak sample location
14: Use b, np, and Table 2 to initialize φi.
15: φi← [σu, σd , µu, µd , γd ,wu,wd , h].
16: n← [0:length(T̂ (n))−1]
17: T iu(n; σu, µu)← construe Gaussian as in (2).
18: T id (n; σd , µd , γd )← construe Lognormal as in (3).




d (x)+ h. See (4).
20: return T ic(n;φi)
21: end procedure
22: procedure LScurveFit(T ic(n;φi))
23: φlow← lower boundaries. See Table 2.
24: φup← upper boundaries. See Table 2.
25: Tc(n;φ) ← Trust-region reflective least-squares
algorithm with the given boundaries.
26: R2← calculate coefficient of determination.
27: return Tc(n;φ),R2
28: end procedure
TABLE 2. Initial values, lower and upper boundaries used to estimate the elements of φ.
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Algorithm 3 Feature Estimation
Input: Delineated T (n)
Output: θδ,TSA
1: To(n)← T (n)
2: T (n),T z(n), type←TwaveRectificationT (n)
3: if type! = flat then
4: Su, Sd ← Estimate T-wave slopes from T z(n) as
in [30].
5: θδ ←EstimateThetaDelta(T (n), Su, Sd )
6: if type! = negative then






12: procedure EstimateThetaDelta(T (n), Su, Sd )
13: θδ ← []
14: N ←length(T (n))
15: σd , µu, µd , γd , R2←TwaveParametrization(T (n))
16: if R2 ≥ 0.8 then
17: θ ← arctan(Sd )− arctan(Su)
18: mu← µu
19: md ← γd + e(µd−σ
2
d )
20: δ̂← md − mu
21: δ← δ̂ N1000




were determined empirically and are dependent on T (n) and
T̂ (n). In the table, np denotes the T-wave peak sample location
of T̂ (n), whereas b = N1000 , where N is the number of
samples in T (n).
FIGURE 11. Template for initialization of the fitting algorithm.
The initial values of φ can be modified as long as the
initial template is similar to the one shown in Fig. 11. The
composite Tc(n) must be beneath T̂ (n) peak. The location
parameterµu ensures that Tu(n) always fits the upward slope,
thus the lower and upper boundaries of µu depend on the
peak location. The boundaries guarantee Tu(n) is centered
within [25%—90%] of the upward portion of T̂ (n) as shown
in Fig 11. The scale parameterµd evaluates how ‘‘shrunk’’ or
‘‘stretched’’ the T-wave is. Accordingly, ln b is used to better
adapt the algorithm to different T-waves.
APPENDIX B
PSEUCODE OF THE DEVELOPED ALGORITHM
T-wave rectification steps are described in Algorithm 1,
T-wave parametrization in Algorithm 2. Algorithm 3 explains
the procedure for feature estimation.
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